142 related articles for article (PubMed ID: 36846693)
1. Synthesis, molecular docking study and anticancer activity of novel 1,3,4-oxadiazole derivatives as potential tubulin inhibitors.
Yousef TA; Alhamzani AG; Abou-Krisha MM; Kanthimathi G; Raghu MS; Kumar KY; Prashanth MK; Jeon BH
Heliyon; 2023 Feb; 9(2):e13460. PubMed ID: 36846693
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducers.
Hagras M; Mandour AA; Mohamed EA; Elkaeed EB; Gobaara IMM; Mehany ABM; Ismail NSM; Refaat HM
RSC Adv; 2021 Dec; 11(63):39728-39741. PubMed ID: 35494162
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
El-Adl K; El-Helby AA; Sakr H; Elwan A
Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme.
El-Adl K; El-Helby AA; Sakr H; Eissa IH; El-Hddad SSA; M I A Shoman F
Bioorg Chem; 2020 Sep; 102():104059. PubMed ID: 32653608
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Molecular Docking Study of New Thiazole Derivatives as Potential Tubulin Polymerization Inhibitors.
El-Abd AO; Bayomi SM; El-Damasy AK; Mansour B; Abdel-Aziz NI; El-Sherbeny MA
ACS Omega; 2022 Sep; 7(37):33599-33613. PubMed ID: 36157722
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site.
Wang G; Peng Z; Zhang J; Qiu J; Xie Z; Gong Z
Bioorg Chem; 2018 Aug; 78():332-340. PubMed ID: 29627654
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells.
Batran RZ; Kassem AF; Abbas EMH; Elseginy SA; Mounier MM
Bioorg Med Chem; 2018 Jul; 26(12):3474-3490. PubMed ID: 29793751
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation.
Hagras M; El Deeb MA; Elzahabi HSA; Elkaeed EB; Mehany ABM; Eissa IH
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):640-658. PubMed ID: 33588683
[TBL] [Abstract][Full Text] [Related]
10. Discovery, biological evaluation, structure-activity relationships and mechanism of action of pyrazolo[3,4-b]pyridin-6-one derivatives as a new class of anticancer agents.
Guo Q; Luo Y; Zhai S; Jiang Z; Zhao C; Xu J; Wang L
Org Biomol Chem; 2019 Jun; 17(25):6201-6214. PubMed ID: 31179474
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors.
Mirzaei S; Eisvand F; Hadizadeh F; Mosaffa F; Ghasemi A; Ghodsi R
Bioorg Chem; 2020 May; 98():103711. PubMed ID: 32179282
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
14. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction.
Wang G; Peng Z; Peng S; Qiu J; Li Y; Lan Y
Bioorg Med Chem Lett; 2018 Nov; 28(20):3350-3355. PubMed ID: 30197030
[TBL] [Abstract][Full Text] [Related]
15. 1,3,4-oxadiazole-2-thione Derivatives; Novel Approach for Anticancer and Tubulin Polymerization Inhibitory Activities.
Abdel-Aziz M; Metwally KA; Gamal-Eldeen AM; Aly OM
Anticancer Agents Med Chem; 2015; 16(2):269-77. PubMed ID: 26343141
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation, and molecular docking of new benzofuran and indole derivatives as tubulin polymerization inhibitors.
El-Sayed NF; El-Hussieny M; Ewies EF; El Shehry MF; Awad HM; Fouad MA
Drug Dev Res; 2022 Apr; 83(2):485-500. PubMed ID: 34523738
[TBL] [Abstract][Full Text] [Related]
17. Novel 1,3-diaryl pyrazole derivatives bearing methylsulfonyl moiety: Design, synthesis, molecular docking and dynamics, with dual activities as anti-inflammatory and anticancer agents through selectively targeting COX-2.
Shaker AMM; Shahin MI; AboulMagd AM; Abdel Aleem SA; Abdel-Rahman HM; Abou El Ella DA
Bioorg Chem; 2022 Dec; 129():106143. PubMed ID: 36191430
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.
Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
Bioorg Chem; 2020 Jan; 95():103565. PubMed ID: 31927336
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and anticancer evaluation of benzophenone derivatives bearing naphthalene moiety as novel tubulin polymerization inhibitors.
Wang G; Liu W; Tang J; Ma X; Gong Z; Huang Y; Li Y; Peng Z
Bioorg Chem; 2020 Nov; 104():104265. PubMed ID: 32919128
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, molecular modeling, and biological evaluation of pyrazole-naphthalene derivatives as potential anticancer agents on MCF-7 breast cancer cells by inhibiting tubulin polymerization.
Wang G; Liu W; Peng Z; Huang Y; Gong Z; Li Y
Bioorg Chem; 2020 Oct; 103():104141. PubMed ID: 32750611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]